Podrobno

Citotoksična aktivnost ekstraktov izbranih antarktičnih morskih spužev : magistrsko delo
ID Čivović, Sandra (Avtor), ID Turk, Tom (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Batista, Urška (Komentor), ID Sepčić, Kristina (Recenzent)

.pdfPDF - Predstavitvena datoteka, prenos (1,43 MB)
MD5: A0E3765F0FFE547AB76E334278FFF10B

Jezik:Slovenski jezik
Ključne besede:morske spužve, antarktične morske spužve, izvlečki morskih spužev, naravni produkti, citotoksična aktivnost, celične linije, celična linija V-79-379A, celična linija CaCo-2, MTS-test
Vrsta gradiva:Magistrsko delo/naloga
Tipologija:2.09 - Magistrsko delo
Organizacija:BF - Biotehniška fakulteta
Kraj izida:Ljubljana
Založnik:[S. Čivović]
Leto izida:2014
Št. strani:XII, 59 f., [10] f. pril.
PID:20.500.12556/RUL-118289 Povezava se odpre v novem oknu
UDK:593.4:547.9:57.083.36
COBISS.SI-ID:4357240 Povezava se odpre v novem oknu
Datum objave v RUL:27.08.2020
Število ogledov:1338
Število prenosov:254
Metapodatki:XML DC-XML DC-RDF
:
ČIVOVIĆ, Sandra, 2014, Citotoksična aktivnost ekstraktov izbranih antarktičnih morskih spužev : magistrsko delo [na spletu]. Magistrsko delo. Ljubljana : S. Čivović. [Dostopano 1 april 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=118289
Kopiraj citat
Objavi na:Bookmark and Share

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Cytotoxic activity of extracts from selected Antarctic marine sponges : M. Sc. Thesis
Ključne besede:marine sponges, Antarctic marine sponges, marine sponge extracts, natural products, citotoxic activity, cell line V-79-379A, cell line CaCo-2, MTS assay

Podobna dela

Podobna dela v RUL:
  1. Systematic review and meta-analysis of observational studies evaluating treatment outcomes in patients with metastatic non-small-cell lung cancer on first-line immune checkpoint inhibitors therapy
  2. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  3. Effectivness and safety of immunotherapy in patients with advanced non-small cell lung cancer in second line treatment at the University Clinic Golnik
  4. Evaluation of possible pembrolizumab dosing regimen racionalisation in advanced non-small cell lung cancer
  5. ǂThe ǂpotential of immunotherapies in the treatment of lung cancer
Podobna dela v drugih slovenskih zbirkah:
  1. ǂThe ǂrole of immune checkpoint inhibitors in the treatment of cancer of unknown origin
  2. Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
  3. Febrile neutropenia and grade 3/4 neutropenia in daily practice of adjuvant chemotherapy for non-small-cell lung cancer
  4. Advances in the therapy with immune-check point inhibitors (ICI) in non-small cell lung cancer (NSCLC) in 2022
  5. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Nazaj